Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-23

Clinical Trial Update: A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas [Phase 3]

View source ↗

Summary

Phase III trial investigating adjuvant temozolomide with or without interferon-alpha in newly diagnosed high-grade gliomas, including anaplastic oligastrocytoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Interferon-alpha (interferon alpha)
  • Temozolomide (Temozolomide)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Anaplastic Oligoastrocytoma, Anaplastic Astrocytoma | Phase 3 | Status: UNKNOWN